Results

Total Results: 500 records

Showing results for "lung".
Users also searched for: lung cancer screening

161. March 3rd Impact of Healthcare Algorithms on Racial and Ethnic Disparities in Healthcare (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-3.pdf
     July 01, 2023 - Cardiovascular risk Healthcare costs of utilization Intensive care needs Kidney function Lung … function Lung cancer screening Opioid misuse Organ donation Postpartum depression Stroke risk … Results Removed race N, Studies 15 Algorithm eGFR for kidney function GLI spirometry equation for lung … cardiovascular disease COAG for warfarin dosing Added health outcome variables 1 USPSTF-2020 for lung

162. Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-immunotherapy-2010/research-protocol

163. Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research

164. Interventions to Modify Healthcare Provider Adherence to Asthma Guidelines | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-provider-adherence/research-protocol

165. Maternal-Fetal Surgical Procedures | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fetal-surgery/technical-brief

166. Disclosure Policy and Form (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
     March 01, 2023 - For an EPC project about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer … for example, report all associations with entities pursuing diagnostic or therapeutic strategies in lung … For an EPC project about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer … for example, report all associations with entities pursuing diagnostic or therapeutic strategies in lung

167. REQUEST FOR TASK ORDER (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
     April 01, 2010 - Seniors with breast, colorectal, lung, or prostate cancer who participated in state pharmaceutical benefit … The retrospective cohort includes patients with a primary diagnosis of primary breast, colorectal, lung … , we identified all patients with a cancer registry-based primary diagnosis of breast, colorectal, lung … individuals with a higher predicted probability of death were older, more likely to be male, have lung … Statins and risk of lung, breast and colorectal cancer.

168. Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/pneumonia-antibiotic-treatment/research

169. Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions — An Update to the 2009 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-biopsy-update/research-protocol

170. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
     February 17, 2016 - These clots are generally smaller and less likely to embolize to the lungs than proximal DVTs Proximal … These clots tend to be relatively large and may be more liable to embolize to the lungs, compared to … embolism: Blockage of the pulmonary artery (the artery carrying deoxygenated blood from the heart to the lungs

171. Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cystic-fibrosis-hgh/research

172. Closing the Quality Gap Series: Prevention of Health Care–Associated Infections | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/health-careassociated-infections/research-protocol

173. Effectiveness of Recombinant Human Growth Hormone in the Treatment of Cystic Fibrosis — Research Protocol Document | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cystic-fibrosis-hgh/research-protocol

174. Assessment and Management of Chronic Cough | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/chronic-cough/research

175. Use of Analytic Hierarchy Process to elicit stakeholder preferences for prioritizing research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/mcda-krishnan.pdf
     August 27, 2012 - 3 Chronic Obstructive Pulmonary Disease (COPD) • Key health condition in US – Most common lung

176. Heart Surgery | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/heart-surgery

177. Executive summary_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
     December 01, 2023 - cosponsored by the National Institutes of Health’s Office of Research on Women’s Health, the National Heart Lung

178. Heart Failure | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/heart-failure

179. Gaucher Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/gaucher-disease

180. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
     January 01, 2014 - LSD, may develop visceral problems (e.g., hepatomegaly, splenomegaly), anemia, thrombocytopenia, lung … Kidney impairment can probably be deleted from the list, and lung involvement is very rare and should … Liver disease can occur rarely, like lung disease. 2. … In the list of Gaucher symptoms, we would recommend removing “lung and kidney impairment” as these are … the most common LSD, may develop hepatomegaly or splenomegaly, anemia, thrombocytopenia, impaired lung